LIMITED JMT NETWORK SERVICES PUBLIC COMPANY LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED K&K SUPERWHOLESALE HATYAI 2009 PUBLIC COMPANY
LIMITED JMT NETWORK SERVICES PUBLIC COMPANY LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED K&K SUPERWHOLESALE HATYAI 2009 PUBLIC COMPANY
LIMITED JMT NETWORK SERVICES PUBLIC COMPANY LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED K&K SUPERWHOLESALE HATYAI 2009 PUBLIC COMPANY
LIMITED JMT NETWORK SERVICES PUBLIC COMPANY LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED K&K SUPERWHOLESALE HATYAI 2009 PUBLIC COMPANY
LIMITED JPARK: JENKONGKLAI PUBLIC COMPANY LIMITED JR: J.R.W. UTILITY PUBLIC COMPANY LIMITED JSP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JTS: JASMINE TECHNOLOGY SOLUTION PUBLIC
Million Baht was 22.79 Million Baht or 92.92% lower from the last year. In 2016, The Company's profit from the sale of machinery and equipment manufacturing is not in use to outsider 10.88 Million Baht and
direct labor and overhead for manufacturing costs. However, the Company could manage to maintain the percentage of revenue and cost of sales comparing to the same period last year. Selling and
Baht 76 and gross profit margin for the second quarter of 2019 was decreased from 20% to 14%. It was due to the increase in cost of sales, which was the result of manufacturing expenses, which were
addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified
pressuring net profit margin 2) higher depreciation resulted from additional investments in plant, machinery, and office renovations to improve production efficiency and reduce production cost, in order to